Analogous to other inflammatory biomarkers, systemic levels of PTX3 also increase as renal function declines and predict increased cardiovascular and overall mortality risk in CKD patients, independent of traditional risk factors [31], [32], [33]. Here, PTX3 is linked to chronic kidney disease.